Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q4 2021 vs. Q3 2021
How the institutions holding Biofrontera Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 15 | +15 |
| Shares | 0 | 701.4K | +701.4K |
| Value | $0 | $5.29M | +$5.29M |
New holders (15)
Institutions that held Biofrontera Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bard Associates Inc | 343,025 | $2.58M | 0.85% |
| Vanguard Group Inc | 153,273 | $1.15M | 0.00% |
| Verition Fund Management LLC | 55,898 | $420.0K | 0.01% |
| Susquehanna International Group, LLP | 51,010 | $384.0K | 0.00% |
| Bank of Montreal | 30,000 | $240.0K | 0.00% |
| Geode Capital Management, LLC | 24,278 | $182.0K | 0.00% |
| Two Sigma Advisers, LP | 18,600 | $140.0K | 0.00% |
| Qube Research & Technologies Ltd | 13,700 | $103.0K | 0.00% |
| BlackRock Inc. | 10,111 | $76.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 900 | $6.77K | 0.00% |
| Advisor Group Holdings, Inc. | 400 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 158 | $1.00K | 0.00% |
| Wells Fargo & Company | 23 | $0 | 0.00% |
| Morgan Stanley | 6 | $0 | 0.00% |
| Royal Bank of Canada | 25 | $0 | 0.00% |
Sold out (0)
Institutions that held Biofrontera Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.